公开(公告)号：EP3377014A1

公开(公告)日：2018-09-26

申请号：EP16798870.8

申请日：2016-11-02

申请人： KCI Licensing, Inc.

发明人： TUCK, Robert ,  MERCER, David, Richard

IPC分类号： A61F13/02 ,  A61F13/00

CPC分类号： A61F13/025 ,  A61F13/00068 ,  A61F13/0216 ,  A61F13/0233 ,  A61F13/0253 ,  A61F13/0256 ,  A61F13/0266 ,  A61L31/028 ,  A61L31/048 ,  A61M1/0088

摘要： In some illustrative examples, a medical drape suitable for treating a tissue site may include an adherent surface including first adherent force profile oriented along a first axis and a second adherent force profile oriented along a second axis. The first adherent force profile may have an average force less than an average force of the second adherent force profile. Other apparatuses, systems, and methods are also provided.

公开(公告)号：EP3348215A1

公开(公告)日：2018-07-18

申请号：EP16850373.8

申请日：2016-09-29

申请人： Shanghai Clinical Engine Technology Development Co., Ltd.

发明人： SUN, Yinghao

IPC分类号： A61B17/52 ,  A61B17/94

CPC分类号： A61L31/028 ,  A61B1/00165 ,  A61B1/00195 ,  A61B1/051 ,  A61B17/22 ,  A61B17/225 ,  A61B34/73 ,  A61B2017/00477 ,  A61B2017/00526 ,  A61B2017/00734 ,  A61B2017/00876 ,  A61B2017/22082 ,  A61B2017/22087 ,  A61L31/02 ,  A61L31/022 ,  A61L31/04 ,  A61L31/048 ,  A61L31/10 ,  A61L31/14 ,  A61L2400/12 ,  B82Y5/00

摘要： The present invention relates to nanoparticles, a preparation method thereof, a stone removal device, a magnetic target separation instrument and its application. The nanoparticles include a nanoparticle core made of magnetic materials, and a nanoparticle shell formed by attaching surface modifier monomers to the nanoparticle core with an initiator and/or a crosslinking agent. The prepared nanoparticles can wrap stones in ureter, and then small stones remaining in body can be removed quickly without damage from the body under the action of the magnetic target separation instrument. The stones can be drawn and moved without injuring ureteral wall, and meanwhile be disposed conveniently without easy shift.

公开(公告)号：EP3277375A1

公开(公告)日：2018-02-07

申请号：EP15719901.9

申请日：2015-04-01

申请人： Yale University ,  Magnus Flow Limited ,  University College London ,  Queen Mary University of London

发明人： FAHMY, Tarek ,  SINUSAS, Albert ,  LEE, Jung, Seok ,  KIM, Dongin ,  MATHUR, Anthony ,  MARTIN, John

IPC分类号： A61N2/06 ,  A61N2/00

CPC分类号： A61K41/0052 ,  A61F2/82 ,  A61F2210/0076 ,  A61F2210/009 ,  A61K35/44 ,  A61K35/545 ,  A61L27/025 ,  A61L27/042 ,  A61L27/047 ,  A61L27/06 ,  A61L27/18 ,  A61L27/306 ,  A61L27/34 ,  A61L27/58 ,  A61L31/022 ,  A61L31/028 ,  A61L31/06 ,  A61L31/088 ,  A61L31/10 ,  A61L31/148 ,  A61L2400/18 ,  A61L2420/02 ,  A61L2420/06 ,  A61L2420/08 ,  A61L2430/20 ,  A61N2/002 ,  A61N2/06

摘要： It has been discovered that iron-platinum ferromagnetic particles can be dispersed in a polymer and coated into or onto, or directly linked to or embedded on to, medical devices and magnetized. The magnetized devices are used to attract, capture, and/or retain magnetically labeled cells on the surface of the device in vivo. The magnetic particles have an iron/platinum core. Annealing the Fe/Pt particle is very important for introducing a L10 interior crystalline phase. The Fe:Pt molar ratio for creation of the crystal phase is important and a molar range of 1.2-3.0 Fe to Pt (molar precursors, i.e. starting compounds) is desired for magnetization. The magnetic force as a whole can be measured with a “Super Conducting Quantum Interference Device”, which is a sensitive magnetometer. The overall magnetic force is in the range from 0.1 to 2.0 Tesla.

公开(公告)号：EP2198898B1

公开(公告)日：2018-01-10

申请号：EP09177439.8

申请日：2009-11-30

申请人： Biotronik VI Patent AG

发明人： Bayer, Ullrich

IPC分类号： A61L31/02 ,  A61L31/08 ,  A61L31/14

CPC分类号： A61L31/148 ,  A61L31/022 ,  A61L31/028 ,  A61L31/088

公开(公告)号：EP2875078B1

公开(公告)日：2017-12-20

申请号：EP13739595.0

申请日：2013-07-12

申请人： President and Fellows of Harvard College

发明人： INGBER, Donald ,  SUPER, Michael ,  LESLIE, Daniel, C. ,  DIDAR, Tohid ,  WATTERS, Alexander, L. ,  BERTHET, Julia, Bellows ,  WATERHOUSE, Anna

IPC分类号： C09D5/16 ,  B08B17/00 ,  B05D3/10 ,  B05D5/08 ,  A61L29/08 ,  A61L33/00 ,  A61L29/16 ,  A61L31/08 ,  A61L31/16 ,  C08L83/00

CPC分类号： A61F2/01 ,  A61B5/00 ,  A61L29/085 ,  A61L29/16 ,  A61L31/028 ,  A61L31/08 ,  A61L31/14 ,  A61L2300/252 ,  A61L2300/256 ,  A61L2300/42 ,  A61L2300/452 ,  A61L2400/18 ,  A61L2420/00 ,  A61M27/002 ,  A61M27/006 ,  C09D5/1662 ,  C09D5/1687 ,  C09D5/1693 ,  G01N33/56916 ,  G01N33/56938 ,  Y10T428/31663 ,  C08L83/00

摘要： Articles, methods of making, and uses for modifying surfaces for simultaneously providing repellency and selective binding of desired moieties are disclosed. The repellant surfaces comprise a substrate and a lubricating layer immobilized over the substrate surface having a lubricating liquid having an affinity with the substrate. The substrate and the lubricating liquid are attracted to each other together by non-covalent attractive forces. The repellent surface further includes a binding group extending over the surface of the lubricating layer and the binding group has an affinity with a target moiety. The lubricating layer and the substrate form a slippery or repellent surface configured and arranged for contact with a material that is immiscible with the lubricating liquid and the immiscible material contains the target moiety.

公开(公告)号：EP3127568A1

公开(公告)日：2017-02-08

申请号：EP15772563.1

申请日：2015-03-24

申请人： Terumo Kabushiki Kaisha

发明人： YOSHIDA, Akira ,  WATANABE, Yuki ,  HORIUCHI, Aiko ,  YOSHIKAWA, Hiroki

IPC分类号： A61M5/28 ,  A61M5/315

CPC分类号： A61K31/58 ,  A61K9/0019 ,  A61L31/028 ,  A61L31/048 ,  A61L31/049 ,  A61M5/28 ,  A61M5/3129 ,  A61M5/31511 ,  A61M5/31513 ,  A61M2005/3104 ,  A61M2005/3131

摘要： A rocuronium bromide injection solution-prefilled syringe (1) of the present invention includes a syringe (2) comprising an outer cylinder (21) made of synthetic resin, a gasket (22) which is accommodated inside the outer cylinder (21) and liquid-tightly slidable inside the outer cylinder, and a seal member (23) for sealing a distal end opening of the outer cylinder (21); and a rocuronium bromide injection solution (3) filled inside the syringe (2). The gasket (22) is formed by vulcanized chlorinated butyl rubber added calcined clay, and said calcined clay is only added as an inorganic filler classified as an inorganic reinforcing agent and an inorganic filling agent.

摘要翻译： 本发明的罗库溴铵注射液预充式注射器（1）包括注射器（2），其包括由合成树脂制成的外筒（21），容纳在外筒（21）内的垫圈（22）和液体 在外筒内部能够可滑动的密封构件（23），用于密封外筒（21）的前端开口部; 和填充在注射器（2）内的罗库溴铵注射溶液（3）。 垫圈（22）由硫化氯化丁基橡胶添加的煅烧粘土形成，并且所述煅烧粘土仅作为分类为无机增强剂和无机填充剂的无机填料加入。

公开(公告)号：EP2976311A1

公开(公告)日：2016-01-27

申请号：EP14705318.5

申请日：2014-02-12

申请人： Bundesrepublik Deutschland, vertreten durch das Bundesministerium für Wirtschaft und Technologie

发明人： BERGER, Georg ,  SPITZER, Andrea ,  NICOLAIDES, Dagmar ,  GÜNSTER, Jens ,  MARX, Heidi

IPC分类号： C04B35/22 ,  A61L27/10 ,  A61L27/12 ,  C04B35/447 ,  C04B35/468 ,  C04B35/626 ,  C04B35/653 ,  C09K3/14 ,  C03C3/112 ,  C03C10/00 ,  C03C10/16

CPC分类号： A61F2/30771 ,  A61F2/28 ,  A61F2002/2835 ,  A61F2002/30906 ,  A61L27/10 ,  A61L27/12 ,  A61L31/026 ,  A61L31/028 ,  B24C1/06 ,  B24C1/08 ,  B24C11/00 ,  B82Y30/00 ,  C03C3/112 ,  C03C4/0007 ,  C03C10/00 ,  C03C10/16 ,  C04B35/14 ,  C04B35/22 ,  C04B35/447 ,  C04B35/468 ,  C04B35/6262 ,  C04B35/64 ,  C04B35/653 ,  C04B2235/3212 ,  C04B2235/3236 ,  C04B2235/3454 ,  C04B2235/36 ,  C04B2235/445 ,  C04B2235/5427 ,  C04B2235/5436 ,  C04B2235/5445 ,  C04B2235/5454 ,  C04B2235/6567 ,  C04B2235/661 ,  C04B2235/668 ,  C04B2235/80 ,  C04B2235/94 ,  C04B2235/96 ,  C09K3/1427

摘要： The invention relates to a sinterable and/or fusible ceramic mass, comprising a long-term stable compound of crystalline phases of apatite, wollastonite, titanite and optionally cristobalite, which is stabilized by a glass phase, and a production process therefor. The ceramic mass can be obtained by sintering a mixture comprising at least the constituents SiO
2 , CaO, P
2 O
5 , MgO, CaF
2 and TiO
2 , on their own or in combination with at least one alkali oxide, the alkali oxide being chosen from NaO
2 and K
2 O. The invention further relates to uses of the sintered material in the form of moldings for strengthening, cleaning, roughening or polishing surfaces of medical implants or as a final prosthesis.

摘要翻译： 公开了一种可烧结和/或可熔陶瓷块，其具有通过玻璃相稳定的磷灰石，硅灰石，钛白石和任选的方英石的长期稳定的结晶相化合物及其制备方法。 陶瓷块可以通过将至少含有SiO 2，CaO，P 2 O 5，MgO，CaF 2和TiO 2的组分的混合物本身或与至少一种碱金属氧化物，碱金属氧化物选自NaO 2和K 2 O来烧结而获得。 本发明还涉及成形制品形式的烧结材料用于加强，清洁，粗糙化或抛光医用植入物表面或作为最终假体的用途。

公开(公告)号：EP2442759A1

公开(公告)日：2012-04-25

申请号：EP10789887.6

申请日：2010-03-15

申请人： Medtronic Vascular Inc.

发明人： BILGE, Iskender

IPC分类号： A61F2/82 ,  A61L27/12 ,  A61L27/58 ,  A61L27/14 ,  A61M29/02

CPC分类号： A61L31/028 ,  A61F2/82 ,  A61F2/90 ,  A61F2/958 ,  A61F2210/0004 ,  A61F2250/003 ,  A61L31/026 ,  A61L31/06 ,  A61L31/123 ,  A61L31/127 ,  A61L31/148 ,  A61L31/16 ,  Y10T442/105 ,  Y10T442/2525 ,  C08L67/04

摘要： A system for treating a vascular condition includes a stent including hydroxyapatite fibers interwoven to define a stent lumen. Another aspect of the invention is a method of manufacturing a stent by forming hydroxyapatite fibers and biodegradable polymeric fibers, and interweaving the fibers to form a stent wall. The hydroxyapatite fibers can be formed by a sol-gel process, followed by spinning of the gel to form the hydroxyapatite fibers.

公开(公告)号：EP1637171B1

公开(公告)日：2009-09-16

申请号：EP05028431.4

申请日：2001-06-08

申请人： PSIMedica Limited

发明人： Aston, Roger c/o pSiMedica Limited ,  Canham, Leigh Trevor c/o pSiMedica Limited

IPC分类号： A61L27/30 ,  A61F2/30

CPC分类号： A61F2/446 ,  A61B17/064 ,  A61B17/68 ,  A61B17/72 ,  A61B17/80 ,  A61B17/86 ,  A61B17/866 ,  A61B2017/00004 ,  A61B2017/0647 ,  A61B2017/0648 ,  A61F2/28 ,  A61F2/2875 ,  A61F2/32 ,  A61F2002/2817 ,  A61F2002/30062 ,  A61F2002/30084 ,  A61F2002/30154 ,  A61F2002/30172 ,  A61F2002/30235 ,  A61F2002/30677 ,  A61F2002/30785 ,  A61F2002/30789 ,  A61F2002/30906 ,  A61F2002/30925 ,  A61F2210/0004 ,  A61F2230/0021 ,  A61F2230/0052 ,  A61F2230/0069 ,  A61F2310/00353 ,  A61L27/025 ,  A61L27/306 ,  A61L27/54 ,  A61L27/56 ,  A61L31/028 ,  A61L31/088 ,  A61L31/146 ,  A61L31/16

摘要： The invention relates to bioactive porous amorphous silicon. More specifically it relates to bioactive porous amorphous silicon that has been porosified by anodization or stain etching. The invention also concerns resorbable porous amorphous silicon. A composite implant material comprising porous silicon for use as an X-ray opaque material is also described.

公开(公告)号：EP1519762B1

公开(公告)日：2009-01-07

申请号：EP03762823.7

申请日：2003-07-09

申请人： LRC PRODUCTS LIMITED

发明人： HILL, David Michael

IPC分类号： A61L31/14 ,  A61L31/02 ,  A61F6/04

CPC分类号： A61L31/028 ,  A61F6/04 ,  A61L31/02 ,  A61L31/14 ,  Y10T428/13 ,  Y10T428/1334 ,  Y10T428/139 ,  Y10T428/1393 ,  Y10T428/2991 ,  Y10T428/2998

摘要： Substantially spherical water-insoluble inorganic particles are used as finishing powders for condoms.